lipoxin a4 has been researched along with resolvin d2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, GK; Bradding, P; Brightling, CE; Jones, DJ; Martin, N; Pavord, ID; Ruddick, A; Wan, H; Woodman, L | 1 |
| Hasturk, H; Herrera, BS; Kantarci, A; Leung, KP; Van Dyke, TE; Zarrough, A | 1 |
| Blumberg, N; Lannan, KL; Phipps, RP; Spinelli, SL | 1 |
| Das, UN; Gundala, NKV; Naidu, VGM | 1 |
| Colas, RA; Dalli, J; De Maeyer, RP; Flint, JD; George, MJ; Gilroy, DW; Motwani, MP; Richard-Loendt, A; Serhan, CN | 1 |
| Aronica, E; Colas, RA; Craparotta, I; Dalli, J; Foerch, P; Frigerio, F; Hansen, TV; Kaminski, RM; Leclercq, K; Marchini, S; Pasqualini, G; Perretti, M; Pistorius, K; Porcu, L; van Vliet, EA; Vandenplas, C; Vezzani, A | 1 |
6 other study(ies) available for lipoxin a4 and resolvin d2
| Article | Year |
|---|---|
Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation.
Topics: Asthma; Cell Degranulation; Cells, Cultured; Coculture Techniques; Docosahexaenoic Acids; Epithelial Cells; Histamine Release; Humans; Immunoglobulin E; Inflammation Mediators; Limit of Detection; Lipoxins; Lung; Mast Cells; Paracrine Communication; Pertussis Toxin; Receptors, Prostaglandin E, EP2 Subtype; Respiratory Mucosa; Xanthones | 2012 |
LXA4 actions direct fibroblast function and wound closure.
Topics: 3T3 Cells; Actins; Animals; Cell Differentiation; Cell Proliferation; Collagen Type I; Collagen Type III; Docosahexaenoic Acids; Fibroblasts; Inflammation; Lipoxins; Mice; Myofibroblasts; Receptors, Formyl Peptide; Transforming Growth Factor beta1; Wound Healing | 2015 |
Maresin 1 induces a novel pro-resolving phenotype in human platelets.
Topics: Adaptor Proteins, Signal Transducing; Blood Platelets; Cardiovascular Diseases; Docosahexaenoic Acids; Hemostasis; Humans; Inflammation; Lipoxins; Myocardial Infarction; Phenotype; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, G-Protein-Coupled | 2017 |
Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo.
Topics: Animals; Apoptosis; Arachidonic Acid; Blood Glucose; Cell Line; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Eicosapentaenoic Acid; gamma-Linolenic Acid; Glucose Transporter Type 2; Homeodomain Proteins; Lipoxins; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase Type II; Pancreas; Rats; Rats, Wistar; Trans-Activators; Tumor Necrosis Factor-alpha | 2017 |
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Anti-Inflammatory Agents; Blister; Chemokines; Cytokines; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Escherichia coli; Humans; Inflammation; Leukocytes; Lipoxins; Male; Middle Aged; Neutrophils; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, G-Protein-Coupled; Receptors, Lipoxin; Skin; Volunteers; Young Adult | 2018 |
n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis.
Topics: Animals; Anticonvulsants; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; CD11b Antigen; Cytokines; Dinoprostone; Disease Models, Animal; Docosahexaenoic Acids; Encephalitis; Epilepsy; Gene Expression Regulation; Hippocampus; Kainic Acid; Leukotriene B4; Lipid Metabolism; Lipoxins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2018 |